Majority owner: Lundbeck's new share structure could double acquisition power

A new proposed split share structure could give Lundbeck’s majority shareholder, the Lundbeck Foundation, the option to maintain influence while enabling billion-dollar investment hunts. Consequently, the pharmaceutical firm’s acquisition capacity could be doubled, the foundation’s CEO says.
Lene Skole, CEO of the Lundbeck Foundation | Photo: Gregers Tycho/ERH
Lene Skole, CEO of the Lundbeck Foundation | Photo: Gregers Tycho/ERH
by CHRISTOPHER DUE KARLSSON, translated by daniel pedersen

Should Lundbeck succeed in adopting a new share structure dividing shares into two categories, the pharmaceutical company could gain the option to go on billion-dollar external financing hunts without the Lundbeck Foundation, majority shareholder, having to relinquish any power.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading